Sector
Healthcare
Industry
Medical - Devices
Employees
154
First IPO Date
December 30, 2015
| Name | Title | Pay | Year Born |
| Kari Eian Krogstad | Chief Executive Officer & President | 4.87M | 1964 |
| Jonas Tysso | Chief R&D Officer | 551,567 | N/A |
| Monica Weiseth | Vice President of QA\Reg | 558,934 | N/A |
| Helge Borslid | Vice President of Operations | 1.7M | N/A |
| Ole Jorgen Robsrud | Managing Director of 3rd party distribution | 1.78M | N/A |
| Ole Arne Eiksund | Chief Business Development Officer | 1.85M | 1967 |
| Hakon Grothe | Chief Innovation Officer | 1.88M | N/A |
| Hæge Johanne Krogh Wetterhus | Vice President of Marketing | 1.91M | 1964 |
| Thomas Jakobsen | Chief Financial Officer | 2.33M | 1969 |
| Mike Karim | Chief Commercial Officer | 3.09M | N/A |
Medistim ASA, established in Oslo, Norway, in 1984, specializes in the innovation, production, servicing, leasing, and global distribution of sophisticated medical devices primarily for cardio-vascular surgical applications. Their market reach extends across the United States, Europe, Asia, and other international regions. A core offering is their MiraQ system, which comes in two distinct configurations: MiraQ Cardiac, specifically engineered for heart surgeries, and MiraQ Vascular, tailored for operations on blood vessels. Both versions seamlessly combine advanced ultrasound imaging with transit time flow measurement (TTFM) capabilities. The company further provides an array of imaging probes for intraoperative use, alongside a diverse selection of flow probes. These include QuickFit TTFM probes, designed for accurate intraoperative measurement of blood volume flow across various surgical scenarios; Vascular TTFM probes, aimed at improving surgical outcomes; and Doppler probes, utilized on the surface of the heart or vessels to identify intramural coronary arteries or precisely locate and quantify the severity of stenoses. Additionally, Medistim engages in the distribution and sales of third-party medical equipment.